Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Machine Learning Reveals the Contribution of Rare Genetic Variants and Enhances Risk Prediction for Coronary Artery Disease in the Japanese Population.

Circulation. Genomic and precision medicine·2026
Same author

Impact of small area-level deprivation on survival outcomes in patients with Cholangiocarcinoma: a population-based multilevel survival analysis.

Frontiers in public health·2026
Same author

Missing Occupation, Missing Risk: Insights From COVID-19 Case Investigation Data in Busan, South Korea.

Journal of preventive medicine and public health = Yebang Uihakhoe chi·2026
Same author

Seroprevalence and Epidemiological Characteristics of Severe Fever with Thrombocytopenia Syndrome in Patients with Chronic Diseases in Korea.

Viruses·2026
Same author

Development and validation of a multimodal data collection system for adolescent mental health management.

Digital health·2026
Same author

Nationwide seroprevalence of severe fever with thrombocytopenia syndrome virus in South Korea: Regional patterns and public health implications.

Ticks and tick-borne diseases·2026

Related Experiment Video

Updated: Sep 3, 2025

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
09:34

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

33.9K

ClinPharmSeq: A targeted sequencing panel for clinical pharmacogenetics implementation.

Seung-Been Lee1, Jong-Yeon Shin1, Nak-Jung Kwon1

  • 1Macrogen Inc, Seoul, Republic of Korea.

Plos One
|July 28, 2022
PubMed
Summary
This summary is machine-generated.

ClinPharmSeq, a new targeted sequencing panel, accurately identifies genetic variants linked to drug response. This platform enables precise drug therapy by reliably detecting common and rare pharmacogenetic (PGx) alleles, including complex structural variations.

More Related Videos

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
05:53

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

10.2K
Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
13:24

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Published on: April 11, 2016

11.9K

Related Experiment Videos

Last Updated: Sep 3, 2025

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
09:34

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

33.9K
Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
05:53

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

10.2K
Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
13:24

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Published on: April 11, 2016

11.9K

Area of Science:

  • Genetics
  • Pharmacology
  • Bioinformatics

Background:

  • Accurate identification of genetic variants is crucial for precision drug therapy.
  • Targeted sequencing offers a cost-effective, high-throughput method for studying genetic variation.

Purpose of the Study:

  • To introduce ClinPharmSeq, a targeted sequencing panel for pharmacogenetic (PGx) research.
  • To evaluate the accuracy and feasibility of ClinPharmSeq for identifying PGx variants and their association with drug response.

Main Methods:

  • Developed ClinPharmSeq, a panel targeting 59 genes associated with PGx phenotypes.
  • Sequenced 64 diverse Coriell samples using ClinPharmSeq and analyzed data with PyPGx.
  • Validated results against existing PGx testing assays and whole genome sequencing data.

Main Results:

  • ClinPharmSeq generated deep-coverage (mean 274x) and uniform sequencing data (94.8% uniformity at 30x).
  • Identified 185 unique star alleles with high concordance (97.6%-97.9%) to previous methods.
  • Achieved 100% accuracy in detecting complex structural variations, including gene deletions and duplications.

Conclusions:

  • ClinPharmSeq is a reliable and accurate platform for PGx testing.
  • The platform facilitates the broad implementation of PGx testing for optimizing individual drug treatments.